retatrutide triple agonist glp-1 gip glucagon From Obesity to Metabolic Health: Why Is a Game-Changer Retatrutide Obesity Triple Agonist Targeting

doi: 10.1152/physrev.00034.2006 [DOI] [PubMed] [Google Scholar] 36

Adherence 14 , 23372345 (2020)

This key reference addresses pharmacological obesity management through the lens of sarcopenia and SO, emphasizing the clinical management of nutritional and functional risks in the older population beyond weight loss

Semaglutide in patients with heart failure with preserved ejection fraction and obesity

This insight further underscores the advantages of ketogenic diets, which emphasize low carbohydrate intake while prioritizing protein and fat, thereby optimizing GLP-1 production and its beneficial effects on hunger and glucose regulation